Navigation Links
PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad

ProductsPROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
Company Bio-Rad
Item PROTEAN Plus Overlay Agarose, 125 ml
Price 
Description PROTEAN Plus overlay agarose is used for second-dimension SDS-PAGE sample setup to secure IPG strips in place in PROTEAN Plus cells. Bromophenol Blue tracking dye is incorporated to allow monitoring of electrophoresis runs. The solution is composed of 0.75% agarose in 1x Tris, glycine, SDS, and 0.003% Bromophenol Blue and is supplied as 125 ml.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PROTEAN II xi Cell, 20 cm, without spacers and combs from Bio-Rad
2. PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
3. PROTEAN II XL Cell, wide format from Bio-Rad
4. PROTEAN II xi Multi-Cell from Bio-Rad
5. PROTEAN II XL Cell, wide format, 2.0 mm from Bio-Rad
6. PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
7. PROTEAN II xi Cell 2-D Conversion Kit. from Bio-Rad
8. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
9. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
10. PROTEAN II xi 2-D Cell from Bio-Rad
11. PROTEAN II Slab Gel Casting Stand, with gaskets from Bio-Rad
Equine TNF ALPHA from AbD Serotec
REact 2 Buffer from Invitrogen
Porcine TNF-alpha (TNFSF1A) ELISpot Development Kit from R&D Systems
5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal) from Molecular Probes (Invitrogen)
Biology Products:
(Date:11/23/2009)...hern California biomedical engineer and cardiologi...to help clinicians distinguish cardiac emergencies... manageable with drugs and lifestyle change. , A...the arteries feeding the heart, offer an inside vi...d vessels, often revealing deposits of a dangerous...
(Date:11/23/2009)...te of General Medical Sciences (NIGMS), part of th...g $42.3 million for grants in scientific areas it ...loped the GO grant program to stimulate biomedical...the American Recovery and Reinvestment Act (Recove...mise to have a significant impact on a field of bi...
(Date:11/23/2009)...sabona is Director of the Interuniversity Professo...rsity and the University of the Basque Country. Th...also has other experts such as researchers in the ...cialists in ethics. , The Interuniversity Profes...sities of Deusto and the Basque Country was create...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 1Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 3Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 4Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 1Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 2Slotted buses keep passengers cool 9279 1Slotted buses keep passengers cool 9279 2
...ruggling with what humans have done to the modern ... according to Professor Greg Gibson,s recently pub... Between Our Genes and Modern Life Is Making Us Si...cal Sciences, suggests the increased rates of dise...due to human genes being unable to cope with the 2...
...MIPAS and GOME-2 instruments, scientists have for ...in the atmosphere. These new measurements will hel...-depleting species and to improve simulations of s...tion of bromine monoxide (BrO) in the atmosphere s...st observed in 2008 when scientists from the Karls...
...Biometric Technology In Support of the Warfighter ...pplications International Corporation (NYSE: SAI...ct by Sensor Technologies Incorporated (STI) to su... Command (CECOM) by providing operations and user ... (TBS). SAIC,s subcontract has a one-year base pe...
Other Biology News:'It takes a genome: How a clash between our genes and modern life is making us sick' 2European satellites provide new insight into ozone-depleting species 2SAIC Awarded $115 Million Subcontract to Support Tactical Biometrics Systems (TBS) 2
(Date:11/19/2009)..., Most people would like to be able to charge the...kly and not too often. A recent discovery made by ...be-based supercapacitors that could do just this. ...sics Letters , Prabhakar Bandaru, a professor in t...ineering, along with graduate student Mark Hoefer,...
(Date:11/19/2009)..., , BLAUVELT, N.Y., Nov. 19 ...at germ extract, responds to a press release issue...he Hungarian company for making false and self-ser... BioSciences. ,, Dr. Hidvegi stated from his o... claim that research on Avemar does not apply to A...
(Date:11/19/2009)..., , BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sults of Tuesday,s Annual Meeting of Shareholders....orporated (Nasdaq: SPEX ) elected the following m...
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera ...e first patient in a randomized Phase 2B study of ...stage development for multiple oncology indication...ized Phase 2 Study of the X-Linked Inhibitor of Ap...tion with High-dose Cytarabine and Idarubicin in A...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2